The majority of the HCC patients in the two cohorts were male (91.18%) with a tumor size of >5 cm at the time of surgery (45.96%), an elevated serum AFP level (47.79%) and with tumors exceeding the Milan and UCSF criteria (63.60 and 54.41%, respectively; Table I). This evidence concerns the gene AFP and neoplasm.